UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 366

Sortiert nach

Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix

Genome Biology, 2023-07, Vol.24 (1), p.172-172, Article 172

2023

Volltextzugriff (PDF)

Resequencing of the TMF-1 (TATA Element Modulatory Factor) regulated protein (TRNP1) gene in domestic and wild canids

Canine medicine and genetics, 2023-11, Vol.10 (1), p.1-10, Article 10

2023

Volltextzugriff (PDF)

Genetic and environmental risk for lymphoma in boxer dogs

Journal of veterinary internal medicine, 2020-09, Vol.34 (5), p.2068-2077

2020

Volltextzugriff (PDF)

Cytochrome b5 and NADH cytochrome b5 reductase: genotype–phenotype correlations for hydroxylamine reduction

Pharmacogenetics and genomics, 2010-01, Vol.20 (1), p.26-37

2010

Volltextzugriff (PDF)

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity

Pharmacogenetics and genomics, 2012-10, Vol.22 (10), p.733-740

2012

Volltextzugriff (PDF)

Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women

Cancer causes & control, 2014-11, Vol.25 (11), p.1513-1521

2014

Volltextzugriff (PDF)

Projective Techniques and Psychological Assessment in Disadvantaged Communities

International journal of applied psychoanalytic studies, 2014-06, Vol.11 (2), p.114-129

2014

Volltextzugriff (PDF)

Sulfonation of environmental chemicals and their metabolites in the polar bear (Ursus maritimus)

Drug metabolism and disposition, 2005-09, Vol.33 (9), p.1341

2005

Volltextzugriff (PDF)

Glucuronidation of polychlorinated biphenylols and UDP-glucuronic acid concentrations in channel catfish liver and intestine

Drug metabolism and disposition, 2008-04, Vol.36 (4), p.623

2008

Volltextzugriff (PDF)

Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast

Toxicological sciences, 2011-06, Vol.121 (2), p.245-256

2011

Volltextzugriff (PDF)

Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim‐sulfamethoxazole prophylaxis

British journal of clinical pharmacology, 2011-04, Vol.71 (4), p.566-574

2011

Volltextzugriff (PDF)

Single nucleotide polymorphisms and microsatellites in the canine glutathione S-transferase pi 1 (GSTP1) gene promoter

Canine medicine and genetics, 2017, Vol.4

2017

Volltextzugriff (PDF)

Dapsone-Associated Methemoglobinemia in a Patient With Slow NAT25B Haplotype and Impaired Cytochrome b5 Reductase Activity

Journal of clinical pharmacology, 2012-02, Vol.52 (2), p.272-278

2012

Volltextzugriff (PDF)

Effects of food natural products on the biotransformation of PCBs

Environmental toxicology and pharmacology, 2008-03, Vol.25 (2), p.211-217

2008

Volltextzugriff (PDF)

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b ₅ expression and impaired reduction of sulfamethoxazole hydroxylamine

Archives of toxicology, 2010-08, Vol.84 (8), p.597-607

2010

Volltextzugriff (PDF)

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine

Archives of toxicology, 2010-08, Vol.84 (8), p.597-607

2010

Volltextzugriff (PDF)

Glucuronidation in the polar bear ( Ursus maritimus)

Marine environmental research, 2004-08, Vol.58 (2), p.475-479

2004

Volltextzugriff (PDF)

Neuropil Variation in the Prefrontal, Motor, and Visual Cortex of Six Felids

Brain, behavior and evolution, 2024, Vol.99 (1), p.25

2024

Volltextzugriff (PDF)

Polymorphisms in canine glutathione S-Transferase (GST) genes: Prevalence and functional relevance

Drug metabolism and pharmacokinetics, 2019-01, Vol.34 (1), p.S24-S24

2019

Volltextzugriff (PDF)

Genetic variability of cytochrome b5 and NADH cytochrome b5 reductase: SNP discovery and characterization

The FASEB journal, 2009-04, Vol.23 (S1)

2009

Volltextzugriff (PDF)

Genotype‐phenotype correlations for polymorphisms in cytochrome b5 and NADH cytochrome b5 reductase and hepatic sulfamethoxazole hydroxylamine reduction

The FASEB journal, 2008-03, Vol.22 (S1)

2008

Volltextzugriff (PDF)

Dapsone‐Associated Methemoglobinemia in a Patient With Slow NAT2 5B Haplotype and Impaired Cytochrome b 5 Reductase Activity

Journal of clinical pharmacology, 2012-02, Vol.52 (2), p.272-278

2012

Volltextzugriff (PDF)

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYBSA, and CYB5R3 in patients with sulfonamide hypersensitivity

Pharmacogenetics and genomics, 2012, Vol.22 (10), p.733-740

2012

Volltextzugriff (PDF)

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b sub(5) expression and impaired reduction of sulfamethoxazole hydroxylamine

Archives of toxicology, 2010-08, Vol.84 (8), p.597-607

2010

Volltextzugriff (PDF)

Phase II biotransformation of xenobiotics in polar bear (Ursus maritimus) and channel catfish (Ictalurus punctatus)

Sacco, James C

2006

Volltextzugriff (PDF)

1 – 25 von 366

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(234)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix

Resequencing of the TMF-1 (TATA Element Modulatory Factor) regulated protein (TRNP1) gene in domestic and wild canids

Genetic and environmental risk for lymphoma in boxer dogs

Cytochrome b5 and NADH cytochrome b5 reductase: genotype–phenotype correlations for hydroxylamine reduction

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity

Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women

Projective Techniques and Psychological Assessment in Disadvantaged Communities

Sulfonation of environmental chemicals and their metabolites in the polar bear (Ursus maritimus)

Glucuronidation of polychlorinated biphenylols and UDP-glucuronic acid concentrations in channel catfish liver and intestine

Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast

Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim‐sulfamethoxazole prophylaxis

Single nucleotide polymorphisms and microsatellites in the canine glutathione S-transferase pi 1 (GSTP1) gene promoter

Dapsone-Associated Methemoglobinemia in a Patient With Slow NAT25B Haplotype and Impaired Cytochrome b5 Reductase Activity

Effects of food natural products on the biotransformation of PCBs

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b ₅ expression and impaired reduction of sulfamethoxazole hydroxylamine

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine

Glucuronidation in the polar bear ( Ursus maritimus)

Neuropil Variation in the Prefrontal, Motor, and Visual Cortex of Six Felids

Polymorphisms in canine glutathione S-Transferase (GST) genes: Prevalence and functional relevance

Genetic variability of cytochrome b5 and NADH cytochrome b5 reductase: SNP discovery and characterization

Genotype‐phenotype correlations for polymorphisms in cytochrome b5 and NADH cytochrome b5 reductase and hepatic sulfamethoxazole hydroxylamine reduction

Dapsone‐Associated Methemoglobinemia in a Patient With Slow NAT2 5B Haplotype and Impaired Cytochrome b 5 Reductase Activity

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYBSA, and CYB5R3 in patients with sulfonamide hypersensitivity

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b sub(5) expression and impaired reduction of sulfamethoxazole hydroxylamine

Phase II biotransformation of xenobiotics in polar bear (Ursus maritimus) and channel catfish (Ictalurus punctatus)

Suchergebnisse filtern